IL179293A0 - Steroid prodrugs with androgenic effect - Google Patents

Steroid prodrugs with androgenic effect

Info

Publication number
IL179293A0
IL179293A0 IL179293A IL17929306A IL179293A0 IL 179293 A0 IL179293 A0 IL 179293A0 IL 179293 A IL179293 A IL 179293A IL 17929306 A IL17929306 A IL 17929306A IL 179293 A0 IL179293 A0 IL 179293A0
Authority
IL
Israel
Prior art keywords
androgenic effect
steroid prodrugs
prodrugs
steroid
androgenic
Prior art date
Application number
IL179293A
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL179293A0 publication Critical patent/IL179293A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL179293A 2004-05-21 2006-11-15 Steroid prodrugs with androgenic effect IL179293A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (en) 2004-05-21 2004-05-21 Steroid prodrugs with androgenic effects
PCT/EP2005/005256 WO2005113575A1 (en) 2004-05-21 2005-05-10 Steroid prodrugs with androgenic effect

Publications (1)

Publication Number Publication Date
IL179293A0 true IL179293A0 (en) 2007-03-08

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179293A IL179293A0 (en) 2004-05-21 2006-11-15 Steroid prodrugs with androgenic effect

Country Status (22)

Country Link
EP (1) EP1747229A1 (en)
JP (1) JP2007538026A (en)
CN (1) CN1993375A (en)
AR (1) AR049547A1 (en)
AU (1) AU2005245568A1 (en)
BR (1) BRPI0510136A (en)
CA (1) CA2564963A1 (en)
CR (1) CR8785A (en)
DE (1) DE102004025986A1 (en)
EA (1) EA200602049A1 (en)
EC (1) ECSP067028A (en)
GT (1) GT200500122A (en)
IL (1) IL179293A0 (en)
MX (1) MXPA06013469A (en)
NO (1) NO20065885L (en)
PA (1) PA8633601A1 (en)
PE (1) PE20060271A1 (en)
SV (1) SV2006002123A (en)
TW (1) TW200613317A (en)
UY (1) UY28911A1 (en)
WO (1) WO2005113575A1 (en)
ZA (1) ZA200610769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
DE102005057408A1 (en) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
CN101708338B (en) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 Prodrug containing sterides structures and high dispersion preparation thereof
CN102964417A (en) * 2012-11-30 2013-03-13 华中药业股份有限公司 Synthetic method of 17-hydroxy tetrahydropyran ether steroid
CN107556258B (en) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 Preparation method of 4-amino-2-chloro-5 (1H-tetrazolyl-5) benzenesulfonamide
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (en) * 1970-07-17 1973-12-15 Hoffmann La Roche Process for the preparation of acyl derivatives
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (en) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroid sulfamates, processes for their preparation and use thereof
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds

Also Published As

Publication number Publication date
ECSP067028A (en) 2006-12-29
JP2007538026A (en) 2007-12-27
AR049547A1 (en) 2006-08-16
WO2005113575A1 (en) 2005-12-01
GT200500122A (en) 2006-01-24
NO20065885L (en) 2006-12-19
BRPI0510136A (en) 2007-10-02
TW200613317A (en) 2006-05-01
EA200602049A1 (en) 2007-06-29
EP1747229A1 (en) 2007-01-31
CA2564963A1 (en) 2005-12-01
ZA200610769B (en) 2008-08-27
CR8785A (en) 2007-02-05
DE102004025986A1 (en) 2005-12-15
CN1993375A (en) 2007-07-04
SV2006002123A (en) 2006-02-15
PE20060271A1 (en) 2006-05-25
UY28911A1 (en) 2005-12-30
MXPA06013469A (en) 2007-01-23
AU2005245568A1 (en) 2005-12-01
PA8633601A1 (en) 2006-07-03

Similar Documents

Publication Publication Date Title
EP1711186A4 (en) Slow release steroid composition
GB2435698B (en) Adjusting local time
EP2114895A4 (en) Talarazole metabolites
DE602007008470D1 (en) Off
EP1999580A4 (en) Integrated multi-server installation
IL176426A0 (en) Di-steroidal prodrugs of estradiol
ZA201002223B (en) Steroidal [3,2-c]pyrazole compounds,with glucocorticoid activity
ZA200610769B (en) Steroid prodrugs with androgenic effect
EP2012795A4 (en) Therapeutic triterpenoids
EP2084443A4 (en) Lead-through
EP2053170A4 (en) Urinal
EP1977052A4 (en) Anti-splashback urinal
IL176427A0 (en) Di-steroidal prodrugs of ethinyl estradiol
IL187632A0 (en) 3-ester prodrugs of ethynylestradiol
EP2178376A4 (en) Lupane-type triterpenoids modified at 30-position and analogues thereof
AP2008004705A0 (en) Pnem prodrugs
IL187633A0 (en) 3-ester prodrugs of estradiol
GB0602621D0 (en) Fastening
GB0421294D0 (en) Bioreductively-activated prodrugs
HK1126225A1 (en) Steroidal compounds as steroid sulphatase inhibitors
GB0610473D0 (en) Shower screen arrangement
GB0515699D0 (en) Prodrugs
GB0421296D0 (en) Bioreductively-activated prodrugs
IL173608A0 (en) 15-d-homosteroids having an androgenic effect
IL187629A0 (en) Steroids having a mixed androgenic and progestagenic profile